CUSIP: 81642T100
Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,586,602
-
Share change
-
+1,974,119
-
Total reported value
-
$3,157,026
-
Price per share
-
$1.22
-
Number of holders
-
13
-
Value change
-
+$2,356,203
-
Number of buys
-
9
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 81642T100?
CUSIP 81642T100 identifies SLS - SELLAS LIFE SCIENCES GROUP I - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2018
-
Previous quarter:
Q2 2018
Recent filing periods for CUSIP 81642T100:
Institutional Holders of SELLAS LIFE SCIENCES GROUP I - COM (SLS) as of Q3 2018
As of 30 Sep 2018,
SELLAS LIFE SCIENCES GROUP I - COM (SLS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,586,602 shares.
The largest 10 holders included
683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, SABBY MANAGEMENT, LLC, MORGAN STANLEY, PANAGORA ASSET MANAGEMENT INC, TWO SIGMA SECURITIES, LLC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and MEEDER ASSET MANAGEMENT INC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.